ClinicalTrials.Veeva

Menu

To Develop and Validate a Nasoendoscopic Intelligent Diagnostic System for Nasopharyngeal Carcinoma

Sun Yat-sen University logo

Sun Yat-sen University

Status

Enrolling

Conditions

Artificial Intelligence
Otolaryngological Disease

Treatments

Diagnostic Test: rigid nasal endoscopes

Study type

Observational

Funder types

Other

Identifiers

NCT04547673
ZSYY2020

Details and patient eligibility

About

Nasopharyngeal carcinoma (NPC) occurs at a high frequency in southern China, northern Africa, and Alaska, with a reported incidence of 30 cases per 100 000 in Guangdong Province. Endoscopic examination and biopsy are the main methods used for detection and diagnosis of NPC. Early NPC patients achieve favourable prognoses after concurrent radiotherapy and chemotherapy in compassion with advanced NPC patients.

Here, the investigators focused on the utility of artificial intelligence to detect early NPC, which based on white light imaging (WLI) and Narrow-band imaging (NBI) nasoendoscopic examination. Having access to this unique population provides an unprecedented opportunity to investigate the effect of intelligent system on diverse nasopharyngeal lesions detection and develop a novel Computer-Aided Diagnosis System.

Enrollment

1,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Older than 18 years of age

Exclusion criteria

  • Refuse to sign the informed consent statement
  • Patients who have contraindications, e.g. coagulation dysfunction, drug allergy.

Trial design

1,000 participants in 2 patient groups

NPC group
Description:
Patients pathologically diagnosed as NPC by agreement of 2 experienced pathologists who were blinded to the corresponding endoscopic assessment.
Treatment:
Diagnostic Test: rigid nasal endoscopes
Non-NPC group
Description:
Patients pathologically diagnosed as non-NPC (including inflammatory hyperplasia, Atypical hyperplasia, Papilloma etc.) by agreement of 2 experienced pathologists who were blinded to the corresponding endoscopic assessment.
Treatment:
Diagnostic Test: rigid nasal endoscopes

Trial contacts and locations

3

Loading...

Central trial contact

Rui He, M.D.; Yihui Wen, Ph.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems